NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report)’s share price dropped 2.2% during trading on Wednesday . The company traded as low as $3.06 and last traded at $3.06. Approximately 588 shares were traded during trading, a decline of 94% from the average daily volume of 9,604 shares. The stock had previously closed at $3.13.
NeurAxis Trading Down 2.2 %
The stock’s 50 day moving average price is $2.97 and its 200 day moving average price is $3.13. The company has a market capitalization of $20.35 million and a price-to-earnings ratio of -0.82.
NeurAxis (NASDAQ:NRXS – Get Free Report) last issued its earnings results on Friday, August 9th. The company reported ($0.42) earnings per share (EPS) for the quarter. The firm had revenue of $0.61 million for the quarter.
NeurAxis Company Profile
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
See Also
- Five stocks we like better than NeurAxis
- Airline Stocks – Top Airline Stocks to Buy Now
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- Financial Services Stocks Investing
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- How to Start Investing in Real Estate
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
